Spelling suggestions: "subject:"bornaviral"" "subject:"borneviral""
241 |
Regulation of apoptosis by the cell cycle related tumour suppressors p53, E2F1 and RbHsieh, Jung-Kuang January 1999 (has links)
No description available.
|
242 |
Transcriptional regulation of the Epstein-Barr virus immediate early genesJenkins, Peter John January 1999 (has links)
No description available.
|
243 |
An investigation into the effect of myristoylation on the interactions between HIV-1 NEF and cellular proteinsBoulton, Victoria J. January 1998 (has links)
No description available.
|
244 |
Targeting hammerhead ribozymes against hepatitis B virusSmith, Richard January 1998 (has links)
No description available.
|
245 |
Variation in the NS5A gene of Hepatitis C Virus in response to interferon alpha therapyMcKechnie, Victoria Margaret January 1999 (has links)
No description available.
|
246 |
Tropism and neutralization of human and simian immunodeficiency virusesMcKnight, Aine Veronica January 1996 (has links)
No description available.
|
247 |
The transmission dynamics of dengue infectionsBartley, Lucy Margaret Antonia January 2000 (has links)
No description available.
|
248 |
Identification and Characterization of A Novel APC Modulating Type 2 Immunity against Influenza Virus InfectionYoo, Jae-Kwang 17 February 2011 (has links)
Herein we describe a novel APC population in mice, designated LAPCs. LAPCs are BM-derived myeloid leukocytes, distinctive from other immune cells. As APCs, LAPCs respond to various virus infections including VACV, CBV3 and influenza A virus. Notably, influenza virus-activated LAPCs capture Ag in the lungs, and migrate into the DLN and spleen with delayed kinetics compared to DCs. In the DLN, influenza virus-activated LAPCs co-localize with T cells and selectively induce Th2 effector cell polarization by cell-cell contact-mediated modulation of GATA-3 expression. In support of a role for LAPCs in anti-influenza T2 immunity, adoptive transfer experiments revealed that influenza virus-activated LAPCs selectively augmented Th2 effector T cell responses in the DLN, increased production of anti-influenza immunoglobulin (Ig) including IgE in peripheral blood and increased levels of IL-5 and eotaxin in BAL fluid in recipient influenza infected mice. LAPC recipient mice exhibited exacerbated pulmonary pathology, with delayed viral clearance and enhanced pulmonary eosinophilia. Collectively, these results highlight the importance of LAPCs as novel immuno-modulators of T2 immunity during influenza A virus infection, which is implicated in both immunoprotection and immunopathology. Subsequently, we examined the immuno-modulatory effect of type-I IFN, specifically IFN-on the immune response against pulmonary influenza virus infection. We have provided evidence that a single dose of IFN- (1×105U) augmented DC migration but inhibited LAPC migration into the DLN. mIFN- treatment skewed the immune balance toward T1 immunity, identified as enhanced T1 effector T cell responses (Th1 and CTL) but diminished T2 effector T cell responses (Th2) in influenza virus infected mice. Finally, IFN- treated mice showed accelerated viral clearance and diminished pulmonary eosinophilia in lung tissue compared to control mice. Taken together, these results suggest that anti-influenza T1 and T2 immunity may be modulated differently by DCs and LAPCs, respectively. Furthermore, these results support the therapeutic potential of type I IFNs, especially IFN-, as an alternative antiviral to control both viral replication and immunopathology induced by influenza A virus infection in humans.
|
249 |
Interferon Regulatory Factor-9 (Irf-9) Mediates Short Term Host Protection, But Promotes Long Term Immune Injury in Evolution of Myocarditis Leading to Dilated CardiomyopathyKonviser, Michael Joshua 17 November 2011 (has links)
Evolution of viral myocarditis to dilated cardiomyopathy (DCM)represents a delicate balance between host innate immunity and T-cell acquired immunity. IRF-9 is a key member of a transcription factor family that regulates type I interferon (IFN) production, critical for innate antiviral protection.
RESULTS: IRF9-/- mice showed dramatically increased mortality compared to the wildtype
littermates (0% WT vs 72% IRF-9-/- on day 14, P<0.0001). On day 42, there was
less cardiac hypertrophy and inflammation in IRF-9-/- mice compared to WT controls
(p<0.05). Onn day 42 there was a dramatic increase in the number of cytotoxic and
helper T-Cells in the wild-type mice that was not observed in the IRF-9-/- spleens
(p<0.05).
CONCLUSIONS: These data suggest a novel dual role of IRF-9 in not only regulating
interferon in acute stage of viral infection in myocarditis, but also late acquired immunity activation, including CD4/8 populations, contributing to the development of chronic cardiomyopathy.
|
250 |
Friendvertising på Facebook - varför delar vi? : En kvalitativ studie av Facebookanvändares till att dela med sig av reklamkampanjer på FacebookTernby, Lovisa, Fröding, Alexandra January 2014 (has links)
Friendvertising är en metod marknadsförare använder sig av för att få konsumenter att själva sprida reklam via sociala nätverk. För att konsumenter ska sprida ett företags budskap krävs att de motiveras till det. Den här studien har undersökt vad som motiverar Facebookanvändare att dela reklam på Facebook, med syfte att skapa förståelse för dessa motiv. Totalt genomfördes fyra gruppintervjuer, med respondenter från gruppen unga studerande. Resultatet visar att Facebookanvändare motiveras att dela för att kunna påverka sin omgivning, kommunicera med vänner och vara altruistiska, samt för att stärka sin identitet. Resultatet visar också att Facebookanvändare anser att reklam bör ha ett nyhets- och underhållningsvärde, och därmed ett egenvärde. Därför kan reklam idag betraktas som en produkt i sig, där innehållet spelar större roll än varumärke och marknadsförd vara.
|
Page generated in 0.03 seconds